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The surface of nanoparticles is often functionalised with polymeric surfactants, in order to increase 
systemic circulation time. This has been investigated mainly for intravenously administered 
nanoparticles. This study aims to elucidate the effect of surface coating with various concentrations 
of polymeric surfactants (PEG and Pluronics F127) on the in vitro protein binding as well as the 
tissue biodistribution, post oral administration, of PLGA nanoparticles. The in vitro protein 
binding varied depending on the polymeric surfactant used. However, in vivo, 1% PEG and 1% 
Pluronics F127 coated particles presented similar biodistribution profiles in various tissues over 
seven days. Furthermore, the percentage of PEG and Pluronics coated particles detected in plasma 
was higher than that of uncoated PLGA particles, indicating that systemic circulation time can also 
be increased with oral formulations. The difference in the in vitro protein binding as a result of the 
different poloxamers used versus similar in vivo profiles of these particles indicates that in vitro 
observations for nanoparticles cannot represent or be correlated to the in vivo behaviour of the 
nanoparticles. Our results therefore suggest that more studies have to be conducted for oral 
formulations to give a better understanding of the kinetics of the particles. 
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